PE20061435A1 - Derivados de alfa-aminoacidos como ligandos del receptor alfa-2-delta - Google Patents
Derivados de alfa-aminoacidos como ligandos del receptor alfa-2-deltaInfo
- Publication number
- PE20061435A1 PE20061435A1 PE2006000431A PE2006000431A PE20061435A1 PE 20061435 A1 PE20061435 A1 PE 20061435A1 PE 2006000431 A PE2006000431 A PE 2006000431A PE 2006000431 A PE2006000431 A PE 2006000431A PE 20061435 A1 PE20061435 A1 PE 20061435A1
- Authority
- PE
- Peru
- Prior art keywords
- alpha
- amino
- ligands
- alkyl
- acid
- Prior art date
Links
- 239000003446 ligand Substances 0.000 title abstract 2
- 150000001371 alpha-amino acids Chemical class 0.000 title 1
- 235000008206 alpha-amino acids Nutrition 0.000 title 1
- -1 INDANYL Chemical class 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- WDAMHXABMOPUPC-VIFPVBQESA-N (2s)-2-amino-4-ethyl-2-methylhexanoic acid Chemical compound CCC(CC)C[C@](C)(N)C(O)=O WDAMHXABMOPUPC-VIFPVBQESA-N 0.000 abstract 1
- 108090000312 Calcium Channels Proteins 0.000 abstract 1
- 102000003922 Calcium Channels Human genes 0.000 abstract 1
- 208000001640 Fibromyalgia Diseases 0.000 abstract 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical group FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 150000001370 alpha-amino acid derivatives Chemical class 0.000 abstract 1
- 150000001408 amides Chemical class 0.000 abstract 1
- 235000001014 amino acid Nutrition 0.000 abstract 1
- 150000001413 amino acids Chemical class 0.000 abstract 1
- 206010015037 epilepsy Diseases 0.000 abstract 1
- 229910052731 fluorine Inorganic materials 0.000 abstract 1
- 239000011737 fluorine Substances 0.000 abstract 1
- WCYWZMWISLQXQU-UHFFFAOYSA-N methyl Chemical group [CH3] WCYWZMWISLQXQU-UHFFFAOYSA-N 0.000 abstract 1
- 208000004296 neuralgia Diseases 0.000 abstract 1
- 208000021722 neuropathic pain Diseases 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/325—Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/401—Proline; Derivatives thereof, e.g. captopril
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4172—Imidazole-alkanecarboxylic acids, e.g. histidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C229/06—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
- C07C229/08—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to hydrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/28—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and containing rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/04—Systems containing only non-condensed rings with a four-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Anesthesiology (AREA)
- Endocrinology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pyrrole Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US67602505P | 2005-04-28 | 2005-04-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20061435A1 true PE20061435A1 (es) | 2007-02-03 |
Family
ID=36677128
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2006000431A PE20061435A1 (es) | 2005-04-28 | 2006-04-25 | Derivados de alfa-aminoacidos como ligandos del receptor alfa-2-delta |
Country Status (27)
| Country | Link |
|---|---|
| US (1) | US7612226B2 (hr) |
| EP (1) | EP1879567A1 (hr) |
| JP (2) | JP4173909B1 (hr) |
| KR (1) | KR100925900B1 (hr) |
| CN (1) | CN101166524B (hr) |
| AP (1) | AP2007004161A0 (hr) |
| AR (1) | AR054441A1 (hr) |
| AU (1) | AU2006238933B2 (hr) |
| BR (1) | BRPI0609879A2 (hr) |
| CA (1) | CA2606353C (hr) |
| CR (1) | CR9472A (hr) |
| DO (1) | DOP2006000095A (hr) |
| EA (1) | EA200701852A1 (hr) |
| GT (1) | GT200600178A (hr) |
| HK (1) | HK1116417A1 (hr) |
| IL (1) | IL185790A0 (hr) |
| MA (1) | MA29408B1 (hr) |
| MX (1) | MX2007010978A (hr) |
| NL (1) | NL1031705C2 (hr) |
| NO (1) | NO20076000L (hr) |
| PE (1) | PE20061435A1 (hr) |
| SV (1) | SV2008002512A (hr) |
| TN (1) | TNSN07400A1 (hr) |
| TW (1) | TW200719889A (hr) |
| UY (1) | UY29498A1 (hr) |
| WO (1) | WO2006114707A1 (hr) |
| ZA (1) | ZA200707678B (hr) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT934061E (pt) | 1996-07-24 | 2003-10-31 | Warner Lambert Co | Isobutilgaba e seus derivados para o tratamento da dor |
| BRPI0609879A2 (pt) * | 2005-04-28 | 2010-05-11 | Pfizer Ltd | derivados de aminoácidos |
| JP2009515943A (ja) * | 2005-11-17 | 2009-04-16 | ファイザー・リミテッド | アミノ酸誘導体 |
| US8278355B2 (en) | 2006-09-12 | 2012-10-02 | Therexcell Pharma Inc. | Isovaline for treatment of pain |
| CN101195583B (zh) * | 2006-12-04 | 2012-07-04 | 四川抗菌素工业研究所有限公司 | 一种光学纯米那普仑及其盐的制备方法 |
| BR122021020474B1 (pt) * | 2008-09-09 | 2022-06-07 | F. Hoffmann-La Roche Ag | Polimorfos de acil sulfonamidas, seu uso, seu processo de preparação e composição farmacêutica que os compreende |
| JP2012176902A (ja) * | 2011-02-25 | 2012-09-13 | Tosoh F-Tech Inc | 新規な光学活性含フッ素化合物、その製造方法及びそれを用いた光学活性３，３，３−トリフルオロアラニンの製造方法 |
| AT514349B1 (de) * | 2013-06-12 | 2018-05-15 | Red Bull Gmbh | Alpha-alkylierte Aminosäuren (AAAAs) |
Family Cites Families (60)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB504209A (en) | 1937-12-14 | 1939-04-21 | Pirelli General Cable Works | Improvements in or relating to electric cables |
| BR6239521D0 (pt) * | 1961-08-09 | 1973-06-14 | Merck & Co Inc | Processo de preparacao de novos amino acidos |
| FR2586562B1 (fr) | 1985-09-02 | 1989-03-10 | Inst Nat Sante Rech Med | Composition pharmaceutique contenant de l'a-methylhistamine |
| DE3811256A1 (de) | 1988-04-02 | 1989-10-19 | Hoechst Ag | (alpha)-trifluormethylaminosaeure-derivate, verfahren zur herstellung von (alpha)-trifluormethylaminosaeure-derivaten und ihre verwendung als arzneimittel |
| WO1991001724A1 (en) | 1989-07-27 | 1991-02-21 | G.D. Searle & Co. | Renal-selective prodrugs for the treatment of hypertension |
| FR2681067B1 (fr) * | 1991-09-10 | 1993-12-17 | Elf Sanofi | Derives heterocycliques n-substitues, leur preparation, les compositions pharmaceutiques en contenant. |
| JPH042899A (ja) | 1990-04-16 | 1992-01-07 | Arakawa Chem Ind Co Ltd | 紙用サイズ剤および該サイズ剤を用いる紙サイジング方法 |
| FR2661909B1 (fr) | 1990-05-09 | 1997-08-14 | Inst Nat Sante Rech Med | Nouveaux composes agonistes du recepteur h3 de l'histamine a usage therapeutique, compositions pharmaceutiques agissant comme agonistes dudit recepteur et procede de preparation. |
| JPH051002A (ja) | 1991-02-15 | 1993-01-08 | Nikko Kyodo Co Ltd | α−アミノ酸の製造方法 |
| CA2068038A1 (en) | 1991-05-08 | 1992-11-09 | Christopher Yee | Enzymatic resolution of .alpha.-tertiary carboxylic acid esters |
| US5993775A (en) | 1991-11-27 | 1999-11-30 | Diatide, Inc. | Radioactively labeled peptides comprising a single thiol moiety |
| GB9200210D0 (en) | 1992-01-07 | 1992-02-26 | British Bio Technology | Compounds |
| AU674553B2 (en) | 1992-10-14 | 1997-01-02 | Merck & Co., Inc. | Fibrinogen receptor antagonists |
| US5362747A (en) | 1992-11-25 | 1994-11-08 | Abbott Laboratories | 2-nitroaryl and 2-cyanoaryl compounds as regulators of nitric oxide synthase |
| GB9325368D0 (en) | 1993-12-10 | 1994-02-16 | Univ Bristol | Organic compounds |
| GB9325360D0 (en) | 1993-12-10 | 1994-02-16 | Univ Bristol | Organic compounds |
| IS4261A (is) | 1994-02-21 | 1995-08-22 | Astra Aktiebolag | Nýir peptíð-ópíóíðar til meðhöndlunar á verkjum og notkun þeirra |
| DE19533617A1 (de) | 1995-09-11 | 1997-03-13 | Degussa | Neues Verfahren zur Herstellung von optisch aktiven alpha-Aminosäuren und alpha-Aminosäure-Derivaten |
| ATE225343T1 (de) | 1995-12-20 | 2002-10-15 | Hoffmann La Roche | Matrix-metalloprotease inhibitoren |
| WO1998014208A1 (en) | 1996-09-30 | 1998-04-09 | President And Fellows Of Harvard College | Reactive ligands and covalent ligand-protein complexes |
| US5962523A (en) | 1996-10-25 | 1999-10-05 | Discovery Laboratories, Inc. | Methods of using butyric acid derivatives to protect against hair loss |
| JPH10333511A (ja) | 1997-05-30 | 1998-12-18 | Ricoh Co Ltd | 画像除去促進液、該画像除去促進液を用いた被記録材の再生方法及び再生装置 |
| JP4205191B2 (ja) | 1997-12-26 | 2009-01-07 | ダイセル化学工業株式会社 | α−アミノニトリル誘導体及びα−アミノ酸の製造方法 |
| KR100876742B1 (ko) | 1998-03-11 | 2009-01-07 | 가부시끼가이샤 소껭 | 피부 건전화제 |
| BR9910130A (pt) * | 1998-04-17 | 2001-01-09 | Kenneth Curry | Derivados de cubana como antagonistas de receptor de glutamato metabotrópico e processo para a sua preparação |
| PL348237A1 (en) | 1998-12-18 | 2002-05-20 | Novo Nordisk As | Fused 1,2,4-thiadiazine derivatives, their preparation and use |
| JP2002533318A (ja) | 1998-12-22 | 2002-10-08 | ニューロサーチ、アクティーゼルスカブ | イオンチャネル調節剤 |
| FR2788271B1 (fr) | 1999-01-07 | 2001-02-09 | Rhone Poulenc Agrochimie | Nouveau procede de preparation d'aminoacides chiraux |
| AU2969800A (en) | 1999-01-22 | 2000-08-07 | Pharmacore, Inc. | A method for the synthesis of compounds of formula 1 and derivatives thereof |
| PL349354A1 (en) | 1999-01-28 | 2002-07-15 | Chugai Pharmaceutical Co Ltd | Substituted phenethylamine derivatives |
| FR2791982B1 (fr) | 1999-04-06 | 2002-12-27 | Inst Nat Sante Rech Med | Inhibiteurs de lta4 hydrolase et leurs applications therapeutiques. |
| WO2001009117A1 (en) | 1999-07-29 | 2001-02-08 | Allellix Neuroscience Inc. | Tricyclic compounds as glycine transport inhibitors |
| FR2796943A1 (fr) | 1999-07-30 | 2001-02-02 | Aventis Pharma Sa | Derives de benzoxazinnes, leur procede de preparation et leur utilisation en therapeutique |
| JP4728548B2 (ja) | 1999-09-07 | 2011-07-20 | 三菱レイヨン株式会社 | 光学活性アミノアルコールの製造方法 |
| KR100876753B1 (ko) | 1999-09-07 | 2009-01-07 | 가부시끼가이샤 소껭 | 피부 건전화제 |
| JP2001081013A (ja) | 1999-09-10 | 2001-03-27 | Soken Kk | 毛髪健全化剤 |
| US7300775B2 (en) | 1999-12-29 | 2007-11-27 | Verenium Corporation | Methods for producing α-substituted carboxylic acids using nitrilases and strecker reagents |
| US6656958B2 (en) | 2000-02-02 | 2003-12-02 | Abbott Laboratories | Substituted pyridine compounds useful for controlling chemical synaptic transmission |
| DE10121026A1 (de) | 2000-05-05 | 2002-02-07 | Basf Ag | Verfahren zur Herstellung von Aldehyden |
| DE10121028A1 (de) | 2000-05-05 | 2002-01-31 | Basf Ag | Verfahren zur Herstellung von Aldehyden |
| WO2001087819A1 (en) | 2000-05-18 | 2001-11-22 | Mitsubishi Rayon Co., Ltd. | PROCESS FOR PRODUCING OPTICALLY ACTIVE α-AMINO ACID AND OPTICALLY ACTIVE α-AMINO ACID AMIDE |
| WO2003011799A1 (en) | 2000-07-31 | 2003-02-13 | Brandeis University | Kinetic resolutions of chirat 3- and 3-substituted carboxylic acids |
| DE10048715A1 (de) | 2000-09-30 | 2004-05-19 | Grünenthal GmbH | Verwendung von Aminosäure zur Behandlung von Schmerz |
| AUPR406901A0 (en) | 2001-03-29 | 2001-04-26 | La Trobe University | Insecticide and method of controlling insects |
| JP4715058B2 (ja) | 2001-08-02 | 2011-07-06 | Ｊｓｒ株式会社 | 感放射性樹脂組成物 |
| JP2003221328A (ja) | 2002-01-29 | 2003-08-05 | Soken Kk | 皮膚健全化剤 |
| US7038073B2 (en) | 2002-05-15 | 2006-05-02 | Genzyme Corporation | Synthesis of 2-alkyl amino acids |
| WO2004013112A1 (en) | 2002-08-01 | 2004-02-12 | Basf Aktiengesellschaft | Pesticidal fluoroalkene derivatives |
| WO2004024709A2 (en) * | 2002-09-13 | 2004-03-25 | Prescient Neuropharma Inc. | Xanthenyl cubane analogs with activity at the metabotropic glutamate receptors |
| EP1584690A1 (en) | 2003-01-10 | 2005-10-12 | Kaneka Corporation | PROCESS FOR PRODUCING OPTICALLY ACTIVE a-METHYLCYSTEINE DERIVATIVE |
| JP2005060311A (ja) * | 2003-08-13 | 2005-03-10 | Mochida Pharmaceut Co Ltd | Ｎ−（ベンゾイル）アミノ酸誘導体を有効成分とするニューロパシー性疼痛治療剤 |
| GB0322140D0 (en) * | 2003-09-22 | 2003-10-22 | Pfizer Ltd | Combinations |
| JPWO2005044780A1 (ja) | 2003-11-10 | 2007-05-17 | 杏林製薬株式会社 | アミノカルボン酸誘導体とその付加塩及びｓ１ｐ受容体調節剤 |
| CA2554735A1 (en) * | 2004-01-30 | 2005-08-11 | Peplin Biolipids Pty Ltd | Therapeutic and carrier molecules |
| GB0405289D0 (en) | 2004-03-09 | 2004-04-21 | Novartis Ag | Organic compounds |
| US20090111837A1 (en) | 2005-03-01 | 2009-04-30 | Peter Cox | Use of pde7 inhibitors for the treatment of neuropathic pain |
| TW200642687A (en) * | 2005-03-01 | 2006-12-16 | Pfizer Ltd | Combinations comprising α-2-δ ligands |
| CA2601508C (en) * | 2005-03-17 | 2012-01-03 | Pfizer, Inc. | Cyclopropanecarboxamide derivatives |
| BRPI0609879A2 (pt) * | 2005-04-28 | 2010-05-11 | Pfizer Ltd | derivados de aminoácidos |
| RS20080233A (en) * | 2005-12-02 | 2009-07-15 | Pfizer Limited, | Spirocyclic quinazoline derivatives as pde7 inhibitors |
-
2006
- 2006-04-19 BR BRPI0609879-7A patent/BRPI0609879A2/pt not_active Application Discontinuation
- 2006-04-19 MX MX2007010978A patent/MX2007010978A/es active IP Right Grant
- 2006-04-19 CN CN2006800141982A patent/CN101166524B/zh not_active Expired - Fee Related
- 2006-04-19 KR KR1020077024860A patent/KR100925900B1/ko not_active IP Right Cessation
- 2006-04-19 JP JP2008508341A patent/JP4173909B1/ja not_active Expired - Fee Related
- 2006-04-19 EA EA200701852A patent/EA200701852A1/ru unknown
- 2006-04-19 WO PCT/IB2006/001086 patent/WO2006114707A1/en active Application Filing
- 2006-04-19 EP EP06727559A patent/EP1879567A1/en not_active Withdrawn
- 2006-04-19 AP AP2007004161A patent/AP2007004161A0/xx unknown
- 2006-04-19 CA CA2606353A patent/CA2606353C/en not_active Expired - Fee Related
- 2006-04-19 AU AU2006238933A patent/AU2006238933B2/en not_active Ceased
- 2006-04-25 PE PE2006000431A patent/PE20061435A1/es not_active Application Discontinuation
- 2006-04-26 AR ARP060101665A patent/AR054441A1/es not_active Application Discontinuation
- 2006-04-26 DO DO2006000095A patent/DOP2006000095A/es unknown
- 2006-04-26 UY UY29498A patent/UY29498A1/es not_active Application Discontinuation
- 2006-04-27 GT GT200600178A patent/GT200600178A/es unknown
- 2006-04-27 NL NL1031705A patent/NL1031705C2/nl not_active IP Right Cessation
- 2006-04-27 TW TW095115092A patent/TW200719889A/zh unknown
- 2006-04-28 SV SV2006002512A patent/SV2008002512A/es not_active Application Discontinuation
- 2006-04-28 US US11/414,422 patent/US7612226B2/en not_active Expired - Fee Related
-
2007
- 2007-09-06 ZA ZA200707678A patent/ZA200707678B/xx unknown
- 2007-09-06 IL IL185790A patent/IL185790A0/en unknown
- 2007-10-25 CR CR9472A patent/CR9472A/es unknown
- 2007-10-26 MA MA30323A patent/MA29408B1/fr unknown
- 2007-10-26 TN TNP2007000400A patent/TNSN07400A1/fr unknown
- 2007-11-21 NO NO20076000A patent/NO20076000L/no not_active Application Discontinuation
-
2008
- 2008-06-18 HK HK08106675.1A patent/HK1116417A1/xx not_active IP Right Cessation
- 2008-07-02 JP JP2008173198A patent/JP2009040767A/ja not_active Ceased
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20061435A1 (es) | Derivados de alfa-aminoacidos como ligandos del receptor alfa-2-delta | |
| AR077701A1 (es) | Compuestos antiproliferativos, conjugados de los mismos, procedimientos para estos, y usos de los mismos | |
| PE20190914A1 (es) | Combinacion farmaceutica de 3-(3-dimetilamino-1-etil-2-metil-propil)-fenol y un antiepileptico | |
| ES2523732T3 (es) | Control de composiciones de copolímeros | |
| AR047972A1 (es) | Derivado de bencimidazol, proceso de obtencion y composiciones farmaceuticas. | |
| PE20021014A1 (es) | Derivados de glutaramida sustituida con n-fenpropilciclopentilo como inhibidores de nep para fsad | |
| CY1117449T1 (el) | Φαινυλιουχα ν-ακυλο παραγωγα αμινων και αμινοξεων, μεθοδοι για την παραγωγη αυτων, μια φαρμακευτικη συνθεση και η χρηση αυτων | |
| CY1116498T1 (el) | Διεργασια για την παρασκευη (r)-(-)-3-(καρβαμοϋλομεθυλ)-5-μεθυλεξανοϊκου οξεος και πρεγκαμπαλινης και συνθεση ενδιαμεσων | |
| EA200701810A1 (ru) | Производное изоксазолина и новый способ его получения | |
| BRPI0518589A2 (pt) | bactÉria corineforme, e, mÉtodo para produzir um l-aminoÁcido | |
| ATE557096T1 (de) | L-tryptophan produzierendes bakterium und verfahren zur produktion von l-tryptophan | |
| ATE415387T1 (de) | Verfahren zur herstellung von benzonitrilen und benzimidosäure-derivaten | |
| SE1651735A1 (en) | Substances for treatment of fatty liver-related conditions | |
| EA201001766A1 (ru) | Новые[f-18]-меченые производные l-глутаминовой кислоты и l-глутамина (i), их применение, а также способ их получения | |
| EA200900732A1 (ru) | Кристаллическая калиевая соль аналогов липоксина а | |
| NZ600910A (en) | Process for the preparation of chelated compounds | |
| UY37987A (es) | Procedimiento para la preparación de (3s)-3-(4-cloro-3-{[(2s,3r)-2-(4-clorofenil)-4,4,4-trifluor-3- metilbutanoil]amino}fenil)-3-ácido ciclopropilpropanoico y su forma cristalina para uso como principio activo farmacéutico. | |
| BR0206730A (pt) | Processo para preparar uma composição de valproato de sódio não-higroscópica, composição farmacêutica não-higroscópia e seu uso | |
| BRPI0814115B8 (pt) | composição farmacêutica compreendendo o composto 11-deóxi-prostaglandina e método para estabilizar o composto | |
| TW200744993A (en) | Crystalline forms of the di-sodium salt of N-(5-chlorosalicyloyl)-8-aminocaprylic acid | |
| CY1111730T1 (el) | Διαδικασια για την παρασκευη γκαμπαπεντινης | |
| RU2014118122A (ru) | Производное бутилфталида, способ его получения и применение | |
| RU2009103818A (ru) | Водная лекарственная композиция 4-[(4-карбоксибутил)-{2-[(4-фенетилбензил)окси)-фенетил}амино)метил)-бензойной кислоты | |
| RU2013108755A (ru) | Терапевтическое средство или профилактическое средство для нейропатической боли | |
| DK1940772T3 (da) | Ny fremgangsmåde til fremstilling af kvaternære syre- og ammoniumsalte |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Refusal |